Rising Women's Health Awareness Drives Growth in the Yeast Infection Treatment Products Market
Yeast Infection Treatment Products Market Overview According to MarketGenics , the global Yeast Infection Treatment Products Market was valued at USD 4.8 billion in 2025 and is projected to reach USD 8.3 billion by 2035 , registering a CAGR of 5.6% during the forecast period (2025–2035). The market is experiencing steady growth due to the increasing prevalence of fungal infections, rising awareness regarding women's intimate health, expanding access to over-the-counter (OTC) antifungal medications, and growing healthcare expenditure worldwide. The increasing incidence of vaginal yeast infections (candidiasis), skin fungal infections, and infections among immunocompromised patients has accelerated demand for effective antifungal creams, oral medications, suppositories, and combination therapies. Moreover, advancements in antifungal drug formulations, improved diagnostic capabilities, and the expansion of e-commerce healthcare platforms are supporting global market growth...